Related Experiment Video
Updated: Aug 28, 2025
07:41
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
Published on: July 20, 2022
2.0K
Renal Dysfunction in Patients with Left Ventricular Assist Device
Lamees I El Nihum1,2, Nina Manian1,2, Priya Arunachalam1,2
1Methodist DeBakey Heart & Vascular Center, Houston Methodist, Houston, Texas, US.
Methodist Debakey Cardiovascular Journal
|September 22, 2022
Summary
Cardiorenal syndrome (CRS) involves complex heart and kidney interactions. Left ventricular assist devices (LVAD) significantly impact renal function in heart failure patients, particularly those with pre-existing kidney issues.
Area of Science:
- Cardiology
- Nephrology
- Medical Devices
Background:
- Late-stage heart failure and renal dysfunction frequently coexist, a condition known as cardiorenal syndrome (CRS).
- Early understanding of CRS pathophysiology focused on reduced cardiac output and renal perfusion.
- Recent evidence points to more complex mechanisms underlying CRS.
Purpose of the Study:
- To review the pathogenesis of cardiorenal syndrome.
- To examine the impact of preoperative renal dysfunction in patients undergoing left ventricular assist device (LVAD) implantation.
- To elucidate the effects of LVAD implantation on postoperative renal function.
Main Methods:
- Literature review focusing on cardiorenal syndrome.
- Analysis of studies concerning left ventricular assist device (LVAD) implantation.
- Examination of the interplay between cardiac and renal function post-LVAD.
Main Results:
- Left ventricular assist devices (LVAD) influence both cardiac and renal function.
- Preoperative renal dysfunction is a critical factor in LVAD patient outcomes.
- The mechanisms of LVAD impact on renal function are complex and not fully understood.
Conclusions:
- LVADs have a significant, multifaceted effect on renal function in heart failure patients.
- Understanding the impact of LVADs on renal function is crucial for managing patients with cardiorenal syndrome.
- Further research is needed to fully elucidate the complex mechanisms involved.
Related Concept Videos
01:22Heart Failure Drugs: Diuretics
459
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
459
01:22Heart Failure VI: Adjunct Therapies
25
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
25
01:30Cardiomyopathy II: Dilated Cardiomyopathy
19
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
01:29Cardiomyopathy V: Interprofessional Care
29
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
29
01:30Heart Failure V: Medical Management
21
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
21
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
489
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
489